Mechanisms of Gastroesophageal Reflux in Critically III Mechanically-Ventilated Patients

G Nind,WH Chen,K Iwakiri,DW Zou,RJ Fraser,R Young,D Sifrim,R Rigda,RH Holloway
DOI: https://doi.org/10.1016/s0016-5085(03)80269-x
IF: 29.4
2003-01-01
Gastroenterology
Abstract:BACKGROUND: Tegaserod (T) is a 5HT4 receptor partial agonist with prokinetic properties.T is approved for treatment of irritable bowel syndrome with constipation.Recently, the approved dose (6mg bid) of T was reported to also increase the rate of gastric emptying (GE) in healthy men (L.Degan, Aliment Pharmaco[ Ther 2001;15:1745-1751).To evaluate whether T can also improve abnormally delayed GE, we studied the effects of different doses of T in patients with dyspeptic symptoms who had delayed GE.METHODS: In a double blind, placebo controlled study, we evaluated the effects of T on GE in 163 patients with gastroparesis and dyspeptic symptoms.Abnormal GE was documented at baseline by scintigraphy using a 99mTc-labeled standard egg substitute meal.Delayed GE was defined as gastric retention (GR) of greater than 6.3% of the test meal at 4 hours.Subjects were then randomized to: T 6mg bid (n=38), T 6rag tid (n=24), T 12rag bid (n=38) or to placebo (P; n=63).After 8 weeks of treatment, GE was again quantitated by scintigraphy at I, 2 and 4 hours using the same method.RESULTS: GR of the test meal at baseline and after 8 weeks of treatment (total daily doses of T were 12rag, 18mg, 24rag) is shown in the Table .GR was consistently reduced by T, especially at 2 and 4 hours after the meal.Although GR was also decreased with P, treatment with T at 18rag and 24rag/day decreased food retention in late phase emptying by about two-fold.In fact 80% of patients given 18rag/ day developed normal GE compared to only 50% of those given P (p less than 0.058).CONCLUSION: T improves GE in patients with gastroparesis and dyspeptic symptoms.
What problem does this paper attempt to address?